Latest News

New research shows that while niacin added to statin therapy increases HDL cholesterol levels it does not improve HDL functionality

While two large clinical trials recently showed that adding niacin to statin therapy failed to improve clinical outcomes despite a significant increase in HDL-C levels, little is known about exactly why the increased HDL-C levels did not reduce the risk of cardiovascular events, including heart attack and stroke. Now, a small study has shown that while niacin increased measured levels of HDL-C, it did not improve the functionality of HDL. This may provide an explanation for the failure of niacin to further reduce cardiovascular risk.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Visual maps use imagery to help connect personal passions with potential careers

  • Pharmacists can significantly improve blood pressure, cholesterol in stroke patients

  • Telemedicine training for rural parents of children with autism

  • Gene variant puts women at higher risk of Alzheimer's than it does men, study finds

  • Outcome of stroke worse for people with infection

  • Exams in cold auditoriums? Better memory at ideal temperature

  • Obesity: Are lipids hard drugs for the brain?

  • New therapy helps to improve stereoscopic vision in stroke patients

  • MRI pinpoints region of brain injury in some concussion patients

  • Outgoing behavior makes for happier humans: Across cultures, extroverts have more fun

  •